Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway

Area of Science:

• Biochemistry
• Genetics
• Pathology

Background:

• Duchenne muscular dystrophy (DMD) involves oxidative stress and chronic inflammation.
• The dystrophin gene mutation causes progressive muscle degeneration in DMD.
• NF-E2-related Factor 2 is a key regulator of antioxidant and anti-inflammatory responses.

Purpose of the Study:

• To investigate the expression and signaling pathway of NF-E2-related Factor 2 in DMD patients.
• To evaluate antioxidant pathway expression during DMD progression across different age groups.
• To explore the link between oxidative stress and inflammation in DMD pathogenesis.

Main Methods:

• Analysis of muscle biopsies from DMD patients categorized into age groups (0-2 and 2-9 years).
• Assessment of enzymatic antioxidant responses, glutathione levels, and oxidative damage.
• Evaluation of inflammatory markers like heme oxygenase 1 and Interleukin-6 (IL-6).
• Utilizing a transgenic mouse model to study IL-6 overexpression and its correlation with disease severity.

Main Results:

• Oxidative stress markers and antioxidant responses varied significantly between age groups, correlating with disease severity.
• Heme oxygenase 1 and IL-6 levels were modulated, indicating a connection between oxidative stress and inflammation.
• In a mouse model, IL-6 overexpression mirrored the antioxidant profile and muscle severity seen in DMD patients.

Conclusions:

• Oxidative stress plays a critical role in the muscle wasting observed in Duchenne muscular dystrophy.
• The study highlights the interplay between oxidative stress and chronic inflammation in DMD.
• Findings suggest potential therapeutic targets within the antioxidant and anti-inflammatory pathways for DMD treatment.